Cryo Cell International (CCEL) Receivables (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Receivables data on file, last reported at $7.7 million in Q1 2026.

• Receivables for Q1 2026 came in at $7.7 million, down 3.97% year-over-year; the trailing twelve-month figure through Feb 2026 was $7.7 million (down 3.97% YoY), and the FY2025 annual result was $7.7 million, down 4.74% from the prior year.
• Receivables was little changed at $7.7 million in Q1 2026 per CCEL's latest filing, from $7.7 million in the prior quarter.
• Over five years, Receivables peaked at $15.2 million in Q2 2022 and troughed at $5.7 million in Q1 2022.
• A 5-year average of $7.8 million and a median of $7.6 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2023: Receivables soared 165.09% in 2022, then slumped 51.57% in 2023.
• A 5-year view of Receivables shows it stood at $6.7 million in 2022, then advanced by 9.2% to $7.3 million in 2023, then advanced by 11.17% to $8.1 million in 2024, then fell by 4.74% to $7.7 million in 2025, then retreated by 0.14% to $7.7 million in 2026.
• Business Quant data shows CCEL's Receivables at $7.7 million in Q1 2026, $7.7 million in Q4 2025, and $7.7 million in Q3 2025.